BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2009
View Archived Issues
Novel Janus kinase 2 inhibitors disclosed by Merck & Co.
Read More
AstraZeneca claims novel phthalazinone derivatives for cancer treatment
Read More
GSK reports novel glycine transporter inhibitors for schizophrenia treatment
Read More
Muscarinic M3 antagonists described by Pfizer for the treatment of COPD and asthma
Read More
Bayer claims novel compounds for the treatment of dyslipidemia
Read More
Biomarker identified for response to tipifarnib-bortezomib in acute myeloid leukemia
Read More
Saracatinib monotherapy shows little efficacy in advanced, castration-resistant prostate cancer
Read More
Novimmune designs antibodies with multiple specificities
Read More
Johnson & Johnson reviews first quarter 2009
Read More
Dainippon discontinues development of AC-3933 for dementia
Read More
Gilead begins phase II trial for integrase-based, single-tablet, once-daily HIV treatment
Read More
VentiRx initiates phase I VTX-1463 trial in allergic rhinitis
Read More
Galapagos and Merck to develop small-molecule drugs in inflammatory diseases
Read More
Preliminary results from ongoing phase I MDX-1401 trial in Hodgkin lymphoma patients reported
Read More
Multivalent, virosome-based breast cancer vaccine deemed safe, well tolerated in phase I trial
Read More
Pregabalin may be beneficial in patients with chronic hepatitis C
Read More
Advaxis initiates drug-licensing discussions in non-U.S. markets for ADXS11-001
Read More
PAION initiates phase Ib study of CNS-7056 in volunteers undergoing colonoscopy
Read More
Pharmacyclics and Servier enter global strategic alliance for PCI-24781
Read More
Adeona to acquire Colwell Clinical Laboratories
Read More
Amarillo supplies oral interferon for Australian human influenza study
Read More
Osiris completes enrollment in phase III Prochymal trial for graft vs. host disease
Read More
The European Commission withdraws marketing authorization for Velosulin
Read More
Gilead acquires CV Therapeutics
Read More
Factor VIIa inhibitors presented by Eisai for the treatment of thrombotic disorders
Read More